[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335097-105":59,"doc-detail-335097-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","micro-rna-dysregulation-in-keratinocyte-carcinomas-clinical-evidence-functional-impact-and-future-directions","Micro RNA Dysregulation in Keratinocyte Carcinomas - Clinical Evidence, Functional Impact, and Future Directions","","Keratinocyte carcinomas—basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC)—are common human cancers, yet miRNA findings remain inconsistent across studies in terms of which specific miRNAs drive disease biology and how they act. This review consolidates clinical evidence for miRNA dysregulation in keratinocyte carcinomas, evaluates validation quality, identifies gaps, and outlines recommendations for future work using studies that measure miRNA levels in cSCC and BCC. It also links miRNAs to regulation of diverse cellular networks and discusses their promise as biomarkers for prognosis and treatment.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/micro-rna-dysregulation-in-keratinocyte-carcinomas-clinical-evidence-functional-impact-and-future-directions/335097/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/micro-rna-dysregulation-in-keratinocyte-carcinomas-clinical-evidence-functional-impact-and-future-directions/335097.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is miRNA dysregulation important in keratinocyte carcinomas?","Question",{"text":113,"@type":114},"MiRNAs help regulate networks of cellular functions, and large-scale changes in tumor cell biology can be driven by miRNA dysregulation. The article links these mechanisms to both tumor progression and clinical relevance.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What problem does the review highlight about existing miRNA research in cSCC and BCC?",{"text":118,"@type":114},"The review notes very little consistency across the literature regarding the identity of individual miRNAs and/or their roles in cSCC biology, and to a lesser extent in BCC.",{"name":120,"@type":111,"acceptedAnswer":121},"How does the review recommend improving future studies?",{"text":122,"@type":114},"It emphasizes combining clinical evidence with experimental elucidation of miRNA targets and functional impact, and calls for further studies—particularly investigating roles of miRNAs as communicators within the tumor microenvironment.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335097,1790118626,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review  \nMicro RNA Dysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions  \nJessica Conley 1,†, Benjamin Genenger 1,†, Bruce Ashford 2,3 and Marie Ranson 1, *  \nCitation: Conley, J.; Genenger, B.; Ashford, B.; Ranson, M. Micro RNADysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions. Int. J. Mol. Sci. 2024, 25, 8493. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25158493  \nAcademic Editor: Ankit Srivastava  \nReceived: 15 July 2024  \nRevised: 30 July 2024  \nAccepted: 2 August 2024  \nPublished: 3 August 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Molecular Horizons, School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2500, Australia; [jrc739@uowmail.edu.au](jrc739@uowmail.edu.au) (J.C.); [bg038@uowmail.edu.au](bg038@uowmail.edu.au) (B.G.)  \n2 Illawarra Shoalhaven Local Health District (ISLHD), NSW Health, Wollongong, NSW 2500, Australia; [bruceash@uow.edu.au](bruceash@uow.edu.au)  \n3 Graduate School of Medicine, University of Wollongong, Wollongong, NSW 2500, Australia  \n* [Correspondence: mranson@uow.edu.au](Correspondence: mranson@uow.edu.au)  \n† These authors contributed equally to this work.  \nAbstract: The keratinocyte carcinomas, basal cell carcinoma (BCC), and cutaneous squamous cell carcinoma (cSCC), are the most common cancers in humans. Recently, an increasing body of literature has investigated the role of miRNAs in keratinocyte carcinoma pathogenesis, progression and their use as therapeutic agents and targets, or biomarkers. However, there is very little consistency in the literature regarding the identity of and/or role of individual miRNAs in cSCC (and to a lesser extent BCC) biology. miRNA analyses that combine clinical evidence with experimental elucidation of targets and functional impact provide far more compelling evidence than studies purely based on clinical findings or bioinformatic analyses. In this study, we review the clinical evidence associated with miRNA dysregulation in KCs, assessing the quality of validation evidence provided, identify gaps, and provide recommendations for future studies based on relevant studies that investigated miRNA levels inhuman cSCC and BCC. Furthermore, we demonstrate how miRNAs contribute to the regulation of a diverse network of cellular functions, and that large-scale changes in tumor cell biology can be attributed to miRNA dysregulation. We highlight the need for further studies investigating the role of miRNAs as communicators between different cell types in the tumor microenvironment. Finally, we explore the clinical benefits of miRNAs as biomarkers of keratinocyte carcinoma prognosis and treatment.  \nKeywords: cutaneous squamous cell carcinoma; basal cell carcinoma; non-melanoma skin cancer; keratinocyte carcinoma; miRNA; micro RNA  \n1. Introduction  \nNon-melanoma skin cancers are the most common human cancer and the majority (>90%) of NMSC is comprised of the keratinocyte carcinomas (KCs), cutaneous squamous cell carcinoma (cSCC), and basal cell carcinoma (BCC) . While BCC is more common (>70% of NMSC) [1], cSCC accounts for 75% of NMSC-related mortality [2] . Due to their common ultraviolet radiation-driven etiology, BCC and SCC share many risk factors including fair skin, age, chronic sun exposure, and hereditary conditions [3,4] . However, the molecular biology of BCC and cSCC differs significantly. Briefly, BCC is driven by aberrant activation of Sonic hedgehog and Smoothened with concurrent loss of PATCHED [5,6] . Conversely, cSCC is typically driven by a mutational inactiva","cbCaipyXVK049UZv","https://ap.wps.com/l/cbCaipyXVK049UZv","pdf",1072975,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"Why is miRNA dysregulation important in keratinocyte carcinomas?\",\"answer\":\"MiRNAs help regulate networks of cellular functions, and large-scale changes in tumor cell biology can be driven by miRNA dysregulation. The article links these mechanisms to both tumor progression and clinical relevance.\"},{\"question\":\"What problem does the review highlight about existing miRNA research in cSCC and BCC?\",\"answer\":\"The review notes very little consistency across the literature regarding the identity of individual miRNAs and/or their roles in cSCC biology, and to a lesser extent in BCC.\"},{\"question\":\"How does the review recommend improving future studies?\",\"answer\":\"It emphasizes combining clinical evidence with experimental elucidation of miRNA targets and functional impact, and calls for further studies—particularly investigating roles of miRNAs as communicators within the tumor microenvironment.\"}]","Micro RNA Dysregulation in Keratinocyte Carcinomas - Clinical Evidence, Functional Impact, and Future Directions | PDF",1790009647,48]